Celgene Corporation (NASDAQ:CELG) Price Target Cut to $120.00
Fort Pitt Capital Group LLC lifted its holdings in Celgene Corporation by 0.6% during the 2nd quarter. Arcadia Investment Management Corp MI now owns 737 shares of the biopharmaceutical company's st...